| Overview |
| bs-1927R-PE |
| PLAUR Polyclonal Antibody, PE Conjugated |
| WB, FCM |
| Human, Mouse, Rat |
| Dog, Cow, Sheep |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PLAUR |
| 201-300/335 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 5329 |
| Q03405 |
| Secreted, Cell membrane |
| CD87; UPAR; URKR; U-PAR; Urokinase plasminogen activator surface receptor; Monocyte activation antigen Mo3; PLAUR; MO3 |
| Acts as a receptor for urokinase plasminogen activator. Plays a role in localizing and promoting plasmin formation. Mediates the proteolysis-independent signal transduction activation effects of U-PA. It is subject to negative-feedback regulation by U-PA which cleaves it into an inactive form. |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
Powered by Bioz